Other
Liver R
- Status: aktiv
- An Observational Multi-center Study to Evaluate Real-World Treatment Outcomes of Durvalumab-based Regimens in Hepatobiliary Cancers
- Kurzinformation
- Ansprechpartner:
Priv. Doz. Dr. med. Jan Peveling-Oberhag
Telefon: 0711 278 54736
E-Mail: j.peveling-oberhag@klinikum-stuttgart.de - Studienzentrale
Telefon: 0711 278 54961, -54539
E-Mail: scc-studienzentrale@klinikum-stuttgart.de
CARP
- Status: aktiv
- Cholangiocarcinoma treatment with radiofrequency ablation or photodynamic therapy
- Kurzinformation
- Ansprechpartner:
Priv. Doz. Dr. med. Jan Peveling-Oberhag
Telefon: 0711 278 54736
E-Mail: j.peveling-oberhag@klinikum-stuttgart.de - Studienzentrale
Telefon: 0711 278 54961, -54539
E-Mail: scc-studienzentrale@klinikum-stuttgart.de